• News

"US Regulators Approve First Ever Blood Thinner for Children to Treat Heart Conditions and Pediatric Cancer" - Mia De Graaf

  • Daily Mail
  • New York, NY
  • (May 16, 2019)

U.S. regulators have approved the first blood-thinner for children to treat congenital heart disease, cancer, trauma and infection. Until now, doctors have been unofficially using adult products to treat kids, however the US Food and Drug Administration has now approved the widely-used injection made by Pfizer, called Fragmin, to be used for pediatric patients over one month old. According to Robert Pass, MD, chief of the division of pediatric cardiology at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis Children’s Hospital the move is “significant.” Dr. Pass added, “Having this agent approved for this use by the FDA is hopefully the first in many further approvals of agents for the treatment of venous thrombosis in children as well as other agents to treat many other pediatric diseases going forward.”

— Robert H. Pass, MD, Senior Faculty, Professor, Pediatrics, Chief, Division of Pediatric Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Kravis Children’s Hospital, Co-Director, Children’s Heart Center, Director, Pediatric Electrophysiology, Mount Sinai Health System

Learn more 

Additional coverage: Express Digest; Konitono